Literature DB >> 3907949

Pulmonary edema at high altitude. Review, pathophysiology, and update.

R B Schoene.   

Abstract

In summary, recent data suggest that HAPE is a permeability type of edema characterized by an influx of cells (primarily alveolar macrophages) and an increased protein concentration when compared with that of controls. A modest inflammatory response may be mitigated by the presence of an inhibitor to neutrophil chemotaxis. Further information would be helpful to document the course of the disease from its early and more subtle manifestations to its severe clinical form. In addition, insight into the role of biochemical mediators may lead to a better understanding and hence, to prevention and treatment of this potentially fatal disease. However, identity of the event or mediator which initiates the leak remains a mystery.

Entities:  

Mesh:

Year:  1985        PMID: 3907949

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  8 in total

1.  Endotracheal intubation and mechanical ventilation following respiratory arrest from high altitude pulmonary edema.

Authors:  J A Litch
Journal:  West J Med       Date:  1999-03

2.  Identification of haptoglobin and apolipoprotein A-I as biomarkers for high altitude pulmonary edema.

Authors:  Yasmin Ahmad; Dhananjay Shukla; Iti Garg; Narendra K Sharma; Saurabh Saxena; V K Malhotra; Kalpana Bhargava
Journal:  Funct Integr Genomics       Date:  2011-07-14       Impact factor: 3.410

3.  Hypoxia-induced increases in pulmonary transvascular protein escape in rats. Modulation by glucocorticoids.

Authors:  T J Stelzner; R F O'Brien; K Sato; J V Weil
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 4.  High altitude pulmonary oedema: still a place for controversy?

Authors:  J P Richalet
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

Review 5.  Pulmonary oedema associated with airway obstruction.

Authors:  S A Lang; P G Duncan; D A Shephard; H C Ha
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

6.  Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier.

Authors:  A J Ellsworth; E F Meyer; E B Larson
Journal:  West J Med       Date:  1991-03

Review 7.  Physical adaptation of children to life at high altitude.

Authors:  K de Meer; H S Heymans; W G Zijlstra
Journal:  Eur J Pediatr       Date:  1995-04       Impact factor: 3.183

Review 8.  High-altitude illnesses: Old stories and new insights into the pathophysiology, treatment and prevention.

Authors:  Martin Burtscher; Urs Hefti; Jacqueline Pichler Hefti
Journal:  Sports Med Health Sci       Date:  2021-04-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.